Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Get past ATS filters
Benefits offered by this job
Competitive executive compensation
Equity options
High-impact scientific contribution
Job summary
A biotechnology company in Oxford is seeking a visionary Vice President of AI & Genomics Platforms for Drug Discovery to lead their computational genomics strategy. This pivotal role will drive AI-enabled target discovery and innovation while managing a high-performing team. Ideal candidates will have a PhD in a relevant field, extensive AI/ML experience in drug discovery, and a proven leadership track record. Join to shape scientific strategies and impact patient outcomes in a leading life sciences hub.
Qualifications
PhD (or equivalent) in Genomics, Computational Biology, Bioinformatics, AI/ML, or related field.
Extensive experience applying AI/ML to genomics in a drug discovery context.
Proven track record leading interdisciplinary teams in biotech or pharmaceutical environments.
Responsibilities
Lead and scale a team of computational biologists, data scientists, software engineers, and genomics specialists.
Define and execute the company’s AI-genomics strategy.
Build and maintain scalable computational platforms for drug discovery.
Collaborate with discovery, translational, and preclinical teams.
Drive innovation by evaluating emerging technologies.
Skills
AI/ML application in genomics
Team leadership
Multi-omics data integration
Computational platform development
Communication and collaboration
Education
PhD in Genomics or related field
Job description
A biotechnology company in Oxford is seeking a visionary Vice President of AI & Genomics Platforms for Drug Discovery to lead their computational genomics strategy. This pivotal role will drive AI-enabled target discovery and innovation while managing a high-performing team. Ideal candidates will have a PhD in a relevant field, extensive AI/ML experience in drug discovery, and a proven leadership track record. Join to shape scientific strategies and impact patient outcomes in a leading life sciences hub.